Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Retrospective Evaluation of Liposarcoma (RELiSa)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03034252
Recruitment Status : Completed
First Posted : January 27, 2017
Last Update Posted : January 27, 2017
Sponsor:
Information provided by (Responsible Party):
Harrasser, Technische Universität München

Brief Summary:
Retrospective Evaluation of Survival after Liposarcoma

Condition or disease Intervention/treatment
Survival , Tumor Procedure: Patients with Liposarcoma

Layout table for study information
Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Retrospective Evaluation of Liposarcoma
Actual Study Start Date : January 2016
Actual Primary Completion Date : January 2017
Actual Study Completion Date : January 2017

Resource links provided by the National Library of Medicine



Intervention Details:
  • Procedure: Patients with Liposarcoma
    Evaluation of Liposarcoma treated in a single center


Primary Outcome Measures :
  1. Survival rate [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patients with Liposarcoma treated at our clinic
Criteria

Inclusion Criteria:

  • Patients with Liposarcoma treated surgically at our clinic

Exclusion Criteria:

  • N/A

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03034252


Locations
Layout table for location information
Germany
Klinikum rechts der Isar
Munich, Bavaria, Germany, 81675
Sponsors and Collaborators
Technische Universität München
Investigators
Layout table for investigator information
Principal Investigator: norbert harrasser Klinikum rechts der Isar

Layout table for additonal information
Responsible Party: Harrasser, Principal Investigator, Technische Universität München
ClinicalTrials.gov Identifier: NCT03034252     History of Changes
Other Study ID Numbers: 448/11
First Posted: January 27, 2017    Key Record Dates
Last Update Posted: January 27, 2017
Last Verified: January 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Liposarcoma
Neoplasms, Adipose Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms
Sarcoma